Krishant Deo completed his PhD in Medicinal Chemistry at Western Sydney University. He then went on to join ANSTO as a Radiochemist, where he worked across commercial and research projects, contributing to the development of both therapeutic and diagnostic radiopharmaceuticals, and medical devices.
His expertise includes manual and automated radiolabelling techniques, with a strong emphasis on method optimisation to enhance process efficiency and reproducibility. Currently based at the University of Sydney’s Brain and Mind Centre (BMC), Krishant is leading initiatives to expand the BMCs radiochemistry platform by enhancing infrastructure, streamlining workflows and supporting collaborative research across multiple disciplines.
He aims to facilitate the transition of radiopharmaceuticals from research to preclinical and clinical applications, supporting advancements in diagnostic imaging within nuclear medicine.
Brain cancer is a rare disease, making it crucial to bring together existing data so researchers and clinicians can continually access and learn from every patient’s experience. Connecting this info
27 October 2026
This afternoon at Parliament House, the Hon Julian Hill (Assistant Minister for International Education) launched a video highlighting how Australia is using world-leading advanced imaging to transfor
19 August 2026
A new international agreement will help ensure that advanced imaging data collected from PET/CT and PET/MR in clinical trials can be reliably compared – making it easier for researchers to collabora
30 March 2026
Musculoskeletal and neurological conditions such as osteoporosis, Parkinson’s Disease or chronic fatigue syndrome affect 4 billion people worldwide. As populations grow and age, the prevalence of th
10 March 2026